Clinical Findings for Early Human Cases of Influenza A(H7N9) Virus Infection, Shanghai, China
Shuihua Lu(Shanghai Public Health Clinical Center), Jing Bao(Peking University), Xiuhong Xi(Shanghai Medical College of Fudan University), Xinian Liu(Shanghai Medical College of Fudan University), Yufang Zheng(Shanghai Public Health Clinical Center), Ye Cao(Xi'an Jiaotong University), Tao Li(Army Medical University), Qingguo Chen(Shanghai Public Health Clinical Center), Yanbing Wang(Shanghai Public Health Clinical Center), Lijun Zhou(Sichuan Center for Disease Control and Prevention), Qingle Wang(Ministry of Public Security of the People's Republic of China), Yunwen Hu(Southern University of Science and Technology), Douglas Lowrie(Shanghai Public Health Clinical Center)
Cited by 23
Related Papers
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
|New England Journal of Medicine|2013|655
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance
|The Lancet|2013|359
Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection
|Proceedings of the National Academy of Sciences|2013|287
Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells
|Nature Communications|2015|276